Medicinal product name Flixotide Inhaler N 125 micrograms pressurised inhalation, suspension
Pharmaceutical form Pressurised inhalation, suspension
Strength 125 µg/dose 
Information from the MAH on shortages Not available
predicted availability date: not notified
Legal status Rx Prescription (Pr.)
KZS NHS Reimbursed medicines
Package leafletMS Word document 05-09-2022 (Sep 7, 2022)
ATC code R03BA05 Drugs for obstructive airway diseases
Information for Marketing authorisation holdersView

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
predicted availability date: not notified
currently no information on availability from any wholesaler N60
(125 µg/1 dose)
  14.86 
KZS*
I000971-01 Outer Outer Sep 7, 2022
Inner Inner Sep 7, 2022
Outer Outer Sep 3, 2021
Inner Inner Jun 8, 2018
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Authorisations for distribution of parallel imported medicines no. I000971
Authorisation for distribution of parallel imported medicines issued Jun 8, 2018
Authorisation for distribution of parallel imported medicines valid till For unlimited time
Marketing authorisation holder, country GlaxoSmithKline (Ireland) Limited, Ireland
Parallel importer, country Sabiedrība ar ierobežotu atbildību “MAGNUM MEDICAL”, Latvia
Country of medicines exporter Czech Republic